UBVEI PHARMACEUTICALS PRIVATE LIMITED
UBVEI PHARMACEUTICALS PRIVATE LIMITED is a KERALA based PRIVATE LIMITED company, Registered at dated 29-NOV-2021 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of UBVEI PHARMACEUTICALS PRIVATE LIMITED is U24290KL2021PTC072610 and registration number is 072610.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ERNAKULAM India. Authorized share capital of UBVEI PHARMACEUTICALS PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 500000. It aspire to serve in MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
UBVEI PHARMACEUTICALS PRIVATE LIMITED has 2 directors SUNIL KUMAR, VANDANA MANIMEL VENUGOPAL,
The registered Email address of UBVEI PHARMACEUTICALS PRIVATE LIMITED is sunimanimel@gmail.com and its registered address is NO 3/512, MANIMEL HOUSE MAVELIKKARA ALAPPUZHA ALAPPUZHA KL 690103 IN KERALA KERALA india 690103.
The current status of UBVEI PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
UBVEI PHARMACEUTICALS PRIVATE LIMITED
ERNAKULAM
ACTIVE
MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS
U24290KL2021PTC072610
29-NOV-2021
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
500000
CONTACT DETAILS
690103
INDIA
NO 3/512, MANIMEL HOUSE MAVELIKKARA ALAPPUZHA ALAPPUZHA KL 690103 IN
sunimanimel@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
07663223 | SUNIL KUMAR | Director | 29/11/2021 |
09416818 | VANDANA MANIMEL VENUGOPAL | Director | 29/11/2021 |
Details Updated by Companies
Quick Links
- All Registered company of KERALA
- Company Registered in KERALA
- All Registered company of ALAPPUZHA in KERALA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.